Associate Director, Commercial Training

Company Description

Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. 

The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together. 

Job Description

Deciphera is seeking an experienced and highly motivated Associate Director, Commercial Training to lead the strategy, design, and execution of training programs that enable the success of the commercial organization in support of the anticipated launch of tirabrutinib, a highly potent and selective Bruton tyrosine kinase (BTK) inhibitor being advanced for patients with relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). PCNSL is a rare and aggressive extra-nodal non-Hodgkin lymphoma with significant unmet need, and tirabrutinib represents an important potential new treatment option for patients facing limited therapeutic choices. The Associate Director, Commercial Training will play a key role in ensuring field readiness by building capabilities across disease state knowledge, product expertise, customer insights, market access dynamics, and selling skills. This individual will partner closely with Sales, Marketing, Medical Affairs, Market Access, Sales Operations, and other cross-functional stakeholders to deliver impactful training programs that support launch readiness, commercialization in a new disease area, and compliant customer engagement. The role also requires the ability to translate brand strategy and clinical data into practical learning experiences, identify capability gaps, and continuously enhance training effectiveness based on field insights and business needs. 

Essential Duties and Responsibilities of the Position: 

• Develop and execute the commercial training strategy aligned with brand objectives, launch timelines, and business priorities for tirabrutinib and the broader hematology commercial organization. 

• Partner with cross-functional leaders to identify capability gaps, prioritize training initiatives, and translate business strategy into impactful training plans and measurable outcomes. 

• Design and deliver comprehensive training programs including onboarding curriculum, disease state education on PCNSL, product training for tirabrutinib, patient journey, customer insights, market access considerations, and advanced selling skills. 

• Implement credentialing and reinforcement programs to build strong field competency, message retention, and sustained customer impact. 

• Create engaging learning experiences using a mix of live, virtual, and digital modalities, as well as reinforcement tools to maximize learner engagement and retention. 

• Lead training strategy and execution for national sales meetings, POAs, regional workshops, launch readiness programs, and preparation for commercialization in a new disease area. 

• Ensure field teams are fully prepared with the knowledge, tools, and franchise-specific capabilities needed for successful market execution. 

• Conduct field rides and gather insights to assess training effectiveness, identify learning gaps, and refine training programs accordingly. 

• Partner with Marketing, Medical, Legal, Regulatory, and Market Access to ensure training content is aligned, accurate, and compliant. 

• Manage the review and approval process for